Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0040 (66.67%)
Apr 22, 2026, 4:00 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $3.98 million as of April 23, 2026. Its market cap has decreased by -94.01% in one year.
Market Cap
3.98M
Enterprise Value
26.59M
Revenue
65.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 3.98M, a decrease of -99.67%. That is a compound annual growth rate of -40.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.98M | -42.31% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 5.28M |
| AccuStem Sciences | 5.14M |
| Mosaic ImmunoEngineering | 5.03M |
| GPL Holdings | 4.17M |
| Bioxytran | 4.12M |
| Nymox Pharmaceutical | 3.57M |
| CASI Pharmaceuticals | 3.49M |
| Oncology Pharma | 3.09M |